Summary
Ethylmorphine is a Schedule II controlled substance in the United States and regulated internationally under Schedule III of the Single Convention on Narcotic Drugs. Contraindications include asthma, respiratory insufficiency, and age under 8 years. The substance is metabolized to morphine by CYP2D6, with significant inter-individual variation in conversion rates affecting efficacy and safety. Users should employ precise scales for dosing and avoid driving or operating heavy machinery. Not marketed in the United States but available as cough suppressant in some European countries.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 40-50mg | 50-100mg | 100-200mg | 200mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|
| Oral | 15-30 min | 45-90 min | 2-3 hrs | 1-6 hrs | 240-0 min |
Tolerance
Build-up
develops within days of regular use; analgesic tolerance faster than respiratory depression tolerance
Reset
7–14 days for partial reset; full reset may take weeks — tolerance loss greatly increases overdose risk
Effects
Positive
- Pain Relief
- Physical Euphoria
- Cough Suppression
- Analgesia
Negative
- Respiratory Depression
- Nausea
- Dry Mouth
- Stomach cramps
- Sedation
- Itchiness
- Difficulty Urinating
- Pupil Constriction
- Relaxant
Positive
- Cognitive Euphoria
- Anxiety Suppression
- Dream Potentiation
- Euphoria
- Mood lift
- Cognitive euphoria
- Anxiety suppression
Negative
- Constipation
- Compulsive Redosing
- Compulsive redosing
Positive
- Visual geometry
Negative
- Decreased Libido
- Appetite Suppression
- Orgasm Suppression
- Appetite suppression
- Spatial disorientation
- Dulled perception
- Internal hallucinations
- Internal hallucination
- Visual and auditory hallucinations